Position in GALT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,324,163
+$578,675 QoQ
Shares Held
285,380
+6.8% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. GALT ranks #51 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in GALT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,324,163 | 285,380 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $745,488 | 267,200 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,353,064 | 325,256 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,527,536 | 360,268 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $774,323 | 366,978 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $236,043 | 193,478 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $179,217 | 138,928 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $225,247 | 81,908 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $197,203 | 87,258 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $131,598 | 55,062 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $86,007 | 51,812 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $99,479 | 51,812 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $74,609 | 51,812 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $109,855 | 52,312 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $70,707 | 62,573 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $101,178 | 62,073 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $76,679 | 58,534 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $94,239 | 58,534 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $98,602 | 47,634 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $192,191 | 49,534 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $166,508 | 52,034 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,336 | 16,284 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $39,388 | 17,584 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $49,619 | 18,584 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $86,392 | 28,233 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $51,961 | 26,511 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||